PCS6422
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PCS6422, covering 2024-10-10 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer [Phase 2]